Medicare Benefits Schedule - Item 32529

Search Results for Item 32529

View Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

32529

32529 - Additional Information

Item Start Date:
01-May-2018
Description Updated:
01-Nov-2022
Schedule Fee Updated:
01-Jul-2024

Group
T8 - Surgical Operations
Subgroup
3 - Vascular
Subheading
1 - Varicose Veins

Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great and small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using cyanoacrylate adhesive, if all of the following apply:

(a) it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer;

(b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux:

(i) ache;

(ii) pain;

(iii) tightness;

(iv) skin irritation;

(v) heaviness;

(vi) muscle cramps;

(vii) limb swelling;

(viii) discolouration;

(ix) discomfort;

(x) any other signs or symptoms attributable to venous dysfunction;

(c) the service does not include radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy;

(d) the service is not associated with a service (on the same leg) to which any of the following items apply:

(i) 32500 to 32507;

(ii) 35200;

        (iii) 59970 to 60021;

        (iv) 60036 to 60045;

        (v) 60060 to 60078;

        (vi) 60500 to 60509;

        (vii) 61109

The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)

Multiple Operation Rule

(Anaes.)

Fee: $903.75 Benefit: 75% = $677.85 85% = $805.05

(See para TN.8.33 of explanatory notes to this Category)

Extended Medicare Safety Net Cap: $90.40


Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

TN.8.33

Varicose Vein Intervention

Claiming Guide for the following procedures:

  1. Sclerotherapy (Item 32500)
  2. Surgical Dissection and Ligation (Items 32507, 32508, 32511, 32514, 32517)
  3. Endovenous Laser Therapy (Items 32520 and 32522) 
  4. Radiofrequency Ablation (Items 32523 and 32526)
  5. Cyanoacrylate adhesive (Items 32528 and 32529)

It is recommended that the medical practitioner performing the above procedures has successfully completed a substantial course of study and training in duplex ultrasound and the management of venous disease, which has been endorsed by their relevant professional organisation.

It is recommended that providers familiarise themselves with the symptoms to be used to assess the severity of chronic venous disease as indicated in the item descriptor. Providers should also refer to the latest Clinical impact, Etiology/Aetiology, Anatomy and Pathophysiology (CEAP) classification description for symptoms, to help determine when intervention is required.

Related Items: 32500 32507 32508 32511 32514 32517 32520 32522 32523 32526 32528 32529


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change